Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: A case control study in a northern Indian population

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1153-1162

  Umar, Meenakshi ^a   Upadhyay, Rohit ^a,b   Khurana, Rohini ^a   Kumar, Shaleen ^a   Ghoshal, Uday Chand ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer susceptibility; Esophageal cancer; Genetic polymorphism; P53 and p73

Indexed keywords

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; GENE DUPLICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HUMAN; INDIAN; INTRON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; P53 GENE; P73 GENE; RISK ASSESSMENT; RISK FACTOR; TUMOR GENE; TUMOR LOCALIZATION; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; INDIA; RISK;

DNA BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; INTRONS; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84860338714     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0844-9     Document Type: Article

References (54)

1. McCabe ML, Dlamini Z (2005) The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 5(7-8):1113-1130. doi:10.1016/j.intimp.2004.11.017 (Pubitemid 40725707)
2. Holmes RS, Vaughan TL (2007) Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17(1):2-9. doi: 10.1016/j.semradonc.2006.09.003 (Pubitemid 44918357)
3. Xu XC (2009) Risk factors and gene expression in esophageal cancer. Methods Mol Biol 471:335-360. doi:10.1007/978-1-59745-416-2-17
4. Shinohara M, Aoki T, Sato S, Takagi Y, Osaka Y, Koyanagi Y, Hatooka S, Shinoda M (2002) Cell cycle-regulated factors in esophageal cancer. Dis Esophagus 15(2):149-154 (Pubitemid 35264638)
5. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88(3):323-331 (Pubitemid 27131374)
6. Lane DP (1994) On the expression of the p53 protein in human cancer. Mol Biol Rep 19(1):23-29 (Pubitemid 2046926)
7. Wu M, Mao C, Chen Q, Cu XW, Zhang WS (2010) Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls. Mol Biol Rep 37(1):339-343. doi:10.1007/s11033-009-9744-7
8. Robert V, Michel P, Flaman JM, Chiron A, Martin C, Charbonnier F, Paillot B, Frebourg T (2000) High frequency in esopha-geal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis 21(4):563-565 (Pubitemid 30214007)
9. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP et al (1992) p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 52(21):6092-6097
10. Matakidou A, Eisen T, Houlston RS (2003) TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18(4):377-385 (Pubitemid 36850206)
11. Mattick JS (1994) Introns: evolution and function. Curr Opin Genet Dev 4(6):823-831
12. Mattick JS (2004) RNA regulation: a new genetics? Nat Rev Genet 5(4):316-323. doi:10.1038/nrg1321 (Pubitemid 38435628)
13. Jost CA, Marin MC, Kaelin WG Jr (1997) p73 is a simian [correction of human] p53-related protein that can induce apop-tosis. Nature 389(6647):191-194. doi:10.1038/38298 (Pubitemid 27400602)
14. Zhu J, Jiang J, Zhou W, Chen X (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 58(22):5061-5065 (Pubitemid 28521161)
15. Cai YC, Yang GY, Nie Y, Wang LD, Zhao X, Song YL, Seril DN, Liao J, Xing EP, Yang CS (2000) Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogen-esis 21(4):683-689 (Pubitemid 30214025)
16. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90(4):809-819 (Pubitemid 27357971)
17. Uys P, van Helden PD (2003) On the nature of genetic changes required for the development of esophageal cancer. Mol Carcinog 36(2):82-89. doi:10.1002/mc.10100 (Pubitemid 36183900)
18. Vineis P, Malats N, Porta M, Real FX (1999) Human cancer, carcinogenic exposures and mutation spectra. Mutat Res 436(2): 185-194 (Pubitemid 129750348)
19. Saeki H, Ohno S, Araki K, Egashira A, Kawaguchi H, Ikeda Y, Morita M, Kitamura K, Sugimachi K (2000) Alcohol consumption and cigarette smoking in relation to high frequency of p53 protein accumulation in oesophageal squamous cell carcinoma in the Japanese. Br J Cancer 82(11):1892-1894. doi:10.1054/bjoc.1999. 1212 (Pubitemid 30307407)
20. Li G, Wang LE, Chamberlain RM, Amos CI, Spitz MR, Wei Q (2004) p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res 64(19):6863-6866. doi:10.1158/0008-5472. CAN-04-1804 (Pubitemid 39330992)
21. Li G, Sturgis EM, Wang LE, Chamberlain RM, Amos CI, Spitz MR, El-Naggar AK, Hong WK, Wei Q (2004) Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squa-mous cell carcinoma of the head and neck. Carcinogenesis 25(10):1911-1916. doi:10.1093/carcin/bgh197 (Pubitemid 39405910)
22. Galli P, Cadoni G, Volante M, De Feo E, Amore R, Giorgio A, Arzani D, Paludetti G, Ricciardi G, Boccia S (2009) A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer 9:137. doi:10.1186/1471-2407-9-137
23. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 58(7):1380-1383 (Pubitemid 28193594)
24. Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K, Mizutani M, Iwata H, Miura S, Xiang J, Tokudome S, Tajima K (2003) Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 10(4):307-311
25. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B (2008) Association of interleukin-6 (-174G[C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin Immunol 128(2):199-204. doi:10.1016/j.clim.2008.03.519
26. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B (2008) Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squa-mous cell esophageal cancer. Toxicol Appl Pharmacol 230(2): 247-251. doi:10.1016/j.taap.2008.02.023
27. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
28. Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F (2008) Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8:32. doi:10.1186/1471-2407-8-32 (Pubitemid 351314953)
29. Gauderman WJ aMJ (2006) QUANTO 1.1. A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydrauscedu/ gxe
30. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B (2009) Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma. Mutat Res 663(1-2):52-59. doi:10.1016/j.mrfmmm.2009.01.007
31. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96(6):434-442 (Pubitemid 38443646)
32. Montesano R, Hollstein M, Hainaut P (1996) Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 69(3):225-235. doi:10.1002/(SICI)1097-0215(19960621)69:3\225:AID- IJC13[3.0.CO;2-6 (Pubitemid 26233303)
33. Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Hatooka S, Shinoda M, Kodera Y, Yamamura Y, Hirai T, Kato T, Tajima K (2002) No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett 181(1): 81-85 (Pubitemid 34326437)
34. Ryan BM, McManus R, Daly JS, Carton E, Keeling PW, Reynolds JV, Kelleher D (2001) A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br J Cancer 85(10):1499-1503. doi:10.1054/bjoc.2001.2066 (Pubitemid 34001580)
35. Ge H, Wang YM, Cao YY, Chen ZF, Wen DG, Guo W, Wang N, Zhang XF, Li Y, Zhang JH (2007) The p73 polymorphisms are not associated with susceptibility to esophageal squamous cell carcinoma in a high incidence region of China. Dis Esophagus 20(4):290-296. doi:10.1111/j.1442-2050.2007.00672.x (Pubitemid 47054757)
36. Ge H, Wang YM, Cao YY, Zhang XF, Li Y, Guo W, Wang N, Zhang JH (2006) Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma. Ai Zheng 25(11):1351-1355
37. Upadhyay R, Malik MA, Zargar SA, Mittal B (2010) OGG1 Ser326Cys polymorphism and susceptibility to esophageal cancer in low and high at-risk populations of northern India. J Gastro-intest Cancer. doi:10.1007/s12029-009- 9124-5
38. Umar M, Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B (2010) Evaluation of MTHFR677C[T polymorphism in prediction and prognosis of esophageal squamous cell carcinoma: a case-control study in a northern Indian population. Nutr Cancer 62(6):743-749. doi:10.1080/01635581003605961
39. Johnson J, Lagowski J, Sundberg A, Lawson S, Liu Y, Kulesz-Martin M (2007) p73 loss triggers conversion to squamous cell carcinoma reversible upon reconstitution with TAp73alpha. Cancer Res 67(16):7723-7730. doi:10.1158/0008-5472.CAN-07-1195 (Pubitemid 47281365)
40. Fan S, Aie J, Wang J, Fan J, Guo X, Guo S, Liu X, Wei J (2006) Expression of p73, ER and PR in esophageal carcinoma and precancerous lesions. Chn German J Clin Oncol 5(6):427-430
41. Masuda N, Kato H, Nakajima T, Sano T, Kashiwabara K, Oyama T, Kuwano H (2003) Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers. Cancer Sci 94(7):612-617 (Pubitemid 36975016)
42. Nimura Y, Mihara M, Ichimiya S, Sakiyama S, Seki N, Ohira M, Nomura N, Fujimori M, Adachi W, Amano J, He M, Ping YM, Nakagawara A (1998) p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer 78(4):437-440. doi:10.1002/(SICI)1097-0215(19981109)78:4\437:AID-IJC8[3.0.CO;2-V (Pubitemid 28481161)
43. Pfeifer D, Arbman G, Sun XF (2005) Polymorphism of the p73 gene in relation to colorectal cancer risk and survival. Carcino-genesis 26(1):103-107. doi:10.1093/carcin/bgh305 (Pubitemid 40207704)
44. Haber DA, Fearon ER (1998) The promise of cancer genetics. Lancet 351(Suppl 2):SII1-SII8
45. Acharya M, Mitra S, Mukhopadhyay A, Khan M, Roychoudhury S, Ray K (2002) Distribution of p53 codon 72 polymorphism in Indian primary open angle glaucoma patients. Mol Vis 8:367-371 (Pubitemid 36153627)
46. Mitra S, Misra C, Singh RK, Panda CK, Roychoudhury S (2005) Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol 58(1):26-31. doi: 10.1136/jcp.2004.019315 (Pubitemid 40070492)
47. Kamangar F, Chow WH, Abnet CC, Dawsey SM (2009) Environmental causes of esophageal cancer. Gastroenterol Clin North Am 38(1):27-57. doi:10.1016/j.gtc. 2009.01.004
48. Misra C, Majumder M, Bajaj S, Ghosh S, Roy B, Roychoudhury S (2009) Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinog 48(9):790-800. doi:10.1002/mc.20523
49. Choi JE, Kang HG, Chae MH, Kim EJ, Lee WK, Cha SI, Kim CH, Jung TH, Park JY (2006) No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population. Biochem Genet 44(11-12):543-550. doi: 10.1007/s10528-006-9056-8 (Pubitemid 46019610)
50. Hu Z, Miao X, Ma H, Tan W, Wang X, Lu D, Wei Q, Lin D, Shen H (2005) Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int J Cancer 114(3):455-460. doi:10.1002/ijc.20746 (Pubitemid 40279969)
51. Niwa Y, Hamajima N, Atsuta Y, Yamamoto K, Tamakoshi A, Saito T, Hirose K, Nakanishi T, Nawa A, Kuzuya K, Tajima K (2004) Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett 205(1):55-60. doi:10.1016/j.canlet.2003.11.014 (Pubitemid 38230139)
52. Niwa Y, Hirose K, Matsuo K, Tajima K, Ikoma Y, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, Hamajima N (2005) Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Cancer Lett 219(2):183-190. doi:10.1016/j.canlet.2004.10.018 (Pubitemid 40269482)
53. De Feo E, Persiani R, La Greca A, Amore R, Arzani D, Rausei S, D'Ugo D, Magistrelli P, van Duijn CM, Ricciardi G, Boccia S (2009) A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat Res 675(1-2):60-65. doi:10.1016/j.mrgentox.2009.02.009
54. Lin YL, Sengupta S, Gurdziel K, Bell GW, Jacks T, Flores ER (2009) p63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet 5(10):e1000680. doi:10.1371/journal. pgen.1000680